Lymphocytopenia is one of the independent risk factors for RP-ILD in MDA5-positive DM-ILD patients, especially the reduction of CD3 + T cells, CD3 + CD4 + T cells, and CD3 + CD8 + T cells [8]. Here, CD4 is linked to interstitial lung disease.